ESR1 and breast cancer: Biological research revealed that both classes of sulfonamide derivatives (9a–l and 12a–l) had cytotoxic activity against estrogen receptor positive breast cancer cells—MCF-7 and estrogen receptor negative breast cancer—MDA-MB-231.